Business in Brief
Delek fills its coffers after selling its European filling stations, and Teva plans to inflict pain on the market share of Pfizer's Celebrex drug.
Delek sells European filling station unit to British buyout fund
register with haaretz
Like us on Facebook and get articles directly in your news feed